Effects of prasugrel vs clopidogrel on platelet function in non-diabetic obese patients with coronary artery disease
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2013
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 28 Nov 2012 New trial record
- 07 Nov 2012 Primary endpoint 'Platelet-Reactivity-Index' has been met.
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.